Evidence map›Paper›PMID 36140017›Full record

ReviewAntibiotics (Basel, Switzerland)2022

Biocontrol of

Honghua Li, Jinpeng Yang, Xinwan Zhang, Xiuli Xu, Fuhang Song, Hehe Li

Open access · goldAbstract readReview
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. The pathogenicity and future treatment strategies ofFrontiers in cellular and infection microbiology · 2026
    Review
  3. Biotherapeutic Potential of Probiotic YeastIndian journal of microbiology · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Co-inoculation ofFrontiers in plant science · 2024
    Article
  8. Article
  9. Antimicrobial Natural Products.Antibiotics (Basel, Switzerland) · 2022
    Article
  10. Gut microbes
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Honghua LiSchool of Light Industry, Beijing Technology and Business University, Beijing 100048, China.
Jinpeng YangSchool of Ocean Sciences, China University of Geosciences, Beijing 100083, China.
Xinwan ZhangSchool of Ocean Sciences, China University of Geosciences, Beijing 100083, China.
Xiuli XuSchool of Ocean Sciences, China University of Geosciences, Beijing 100083, China.
Fuhang SongSchool of Light Industry, Beijing Technology and Business University, Beijing 100048, China.ORCID 0000-0002-9162-3355
Hehe LiSchool of Light Industry, Beijing Technology and Business University, Beijing 100048, China.
Beijing Technology and Business University · CNChina University of Geosciences (Beijing) · CN

Funding

General Projects of Science and Technology Program of Beijing Municipal Education Commission KM202210011008Research Foundation for Advanced Talents of Beijing Technology and Business University 19008021176Research Foundation for Young Teachers of Beijing Technology and Business University QNJJ2022-21the Key Lab of Marine Bioactive Substance and Modern Analytical Technique, SOA MBSMAT-2019-06
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antagonistic microorganismsbioactive compoundsbiocontrol strategyCandida albicans

Identifiers

PMID36140017
PMCPMC9495215
OpenAlexW4295548784

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.